Forty Seven, Rocket collaborate on new treatment for Fanconi Anemia

This article was originally published here

Forty Seven and Rocket Pharmaceuticals have entered into a research collaboration for evaluating a new treatment regimen in Fanconi Anemia, a rare paediatric disease. Fanconi Anemia affects the

The post Forty Seven, Rocket collaborate on new treatment for Fanconi Anemia appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply